While working alone, you decide to initiate colchicine for a patient with a new gout diagnosis. Which action is most appropriate?

• A. Refer to a specialist before prescribing
• B. Prescribe and dispense the medication for the same patient but take a mental break between both activities
• C. Prescribe only and do not dispense until another pharmacist is available
• D. Delay prescribing until a colleague can supervise

Answer: (B)

Initiating a treatment like colchicine requires careful safety checks because it has a narrow therapeutic window and potential for serious interactions and side effects. When you’re working alone, the safest approach is to proceed with prescribing and dispensing, but insert a deliberate mental break between the two steps. This pause acts as a safety buffer, giving you a moment to re-evaluate key factors: the patient’s renal function and concomitant medicines (to avoid interactions that raise toxicity, such as with certain antibiotics, statins, or P-gp/CYP inhibitors), the correct dosing for an acute gout episode, and the patient’s understanding of how to take the medication and what to monitor (GI symptoms, signs of toxicity).

Prescribing now allows timely treatment for the patient, while the break helps ensure you don’t overlook important details during the dispensing step. If the situation were more complex (e.g., suspected misdiagnosis, significant comorbidities, or high-risk interactions), seeking another professional review would be appropriate, but for a straightforward new gout case, this approach balances prompt care with safety. Delaying therapy or seeking supervision in advance would unnecessarily postpone relief for the patient, especially when a break can mitigate error risk anyway.